{"id":620584,"date":"2022-10-11T17:28:01","date_gmt":"2022-10-11T17:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=620584"},"modified":"2022-10-11T17:28:01","modified_gmt":"2022-10-11T17:28:01","slug":"spasticity-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-jazz-pharmaceuticals-revance-therapeutics-ipsen-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/spasticity-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-jazz-pharmaceuticals-revance-therapeutics-ipsen-and-others_620584.html","title":{"rendered":"Spasticity Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies &#8211; Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1665490120.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Spasticity Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others \" src=\"https:\/\/www.abnewswire.com\/uploads\/1665490120.jpeg\" alt=\"Spasticity Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others \" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Spasticity market is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Spasticity pipeline products will significantly revolutionize the Spasticity market dynamics.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s<strong> &ldquo;Spasticity Market Insights, Epidemiology, and Market Forecast-2032&Prime;<\/strong> report offers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The Spasticity market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current &amp; forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers &amp; barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To Know in detail about the Spasticity market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/spasticity-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Spasticity Market Insights<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Spasticity is defined as &ldquo;sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyper excitability of the stretch reflex&rdquo; or from an upper motor neuron lesion (UMN),presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and\/or lower limbs.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Spasticity Market Report: &nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Spasticity market size is anticipated to grow with a significant <strong>CAGR<\/strong> during the study period <strong>(2019-2032)&nbsp;<\/strong><\/li>\n<li>Spasticity is one of the most common symptoms of multiple sclerosis (MS) and is defined as muscle stiffness that is frequently generalized and that causes more or less continuous rigidity&nbsp;<\/li>\n<li>There were approximately<strong> 2,328,000 prevalent cases<\/strong> of Spasticity in the United States in 2021&nbsp;<\/li>\n<li>According to the analysis, DelveInsight estimated approximately <strong>415,000 prevalent cases<\/strong> of Spasticity in Germany in 2021<\/li>\n<li><strong>Key Spasticity Companies:<\/strong> Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others&nbsp;<\/li>\n<li><strong>Key Spasticity Therapies:<\/strong> Nabiximols, DAXI, IPN10200, and others&nbsp;<\/li>\n<li>The Spasticity epidemiology based on gender analyzed that Males are more at risk of developing Spasticity in comparison to the females&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Get a Free sample for the Spasticity Market Report &#8211;&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/spasticity-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">https:\/\/www.delveinsight.com\/sample-request\/spasticity-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the Spasticity Market report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Spasticity market report covers a descriptive overview and comprehensive insight of the Spasticity Epidemiology and Spasticity market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Spasticity market report provides insights on the current and emerging therapies.<\/li>\n<li>Spasticity market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Spasticity market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Spasticity market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the report to understand which factors are driving Spasticity epidemiology trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/spasticity-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Spasticity Epidemiological Insights<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Market &nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the Spasticity market are anticipated to change in the coming years owing to the expected launch of emerging therapies such and others during the forecasted period 2019-2032. &nbsp;<\/p>\n<p style=\"text-align: justify;\"><em>&ldquo;The emerging therapies for the treatment of Spasticity include <strong>Nabiximols, DAXI<\/strong> and others. Approval of these therapies will provide new and different treatment options to the patients and will hence drive the market.&rdquo;&nbsp;<\/em><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\">The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Epidemiology Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The Spasticity market report proffers epidemiological analysis for the study period 2019&ndash;2032 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalence of Spasticity<\/li>\n<li>Prevalent Cases of Spasticity by severity<\/li>\n<li>Gender-specific Prevalence of Spasticity<\/li>\n<li>Diagnosed Cases of Episodic and Chronic Spasticity<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Drugs Uptake and Pipeline Development Activities<\/strong><\/p>\n<p style=\"text-align: justify;\">The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spasticity market or expected to get launched during the study period. The analysis covers Spasticity market uptake by drugs, patient uptake by therapies, and sales of each drug.&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.<\/p>\n<p style=\"text-align: justify;\">The report also covers the Spasticity Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover more about therapies set to grab major Spasticity market share @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/spasticity-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Spasticity market forecast<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Spasticity Therapies and Key Companies in the market include-<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Nabiximols:<\/strong> Jazz Pharmaceuticals<\/li>\n<li><strong>DAXI:<\/strong> Revance Therapeutics<\/li>\n<li><strong>IPN10200:<\/strong> Ipsen<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Spasticity Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period: 2019&ndash;2032<\/strong><\/li>\n<li><strong>Coverage:<\/strong> 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/li>\n<li><strong>Key Spasticity Companies:<\/strong> Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others<\/li>\n<li><strong>Key Spasticity Therapies:<\/strong> Nabiximols, DAXI, IPN10200, and others<\/li>\n<li><strong>Spasticity Therapeutic Assessment:<\/strong> Spasticity current marketed and Spasticity emerging therapies<\/li>\n<li><strong>Spasticity Market Dynamics:<\/strong>&nbsp; Spasticity market drivers and Spasticity market barriers&nbsp;<\/li>\n<li><strong>Competitive Intelligence Analysis:<\/strong> SWOT analysis, PESTLE analysis, Porter&rsquo;s five forces, BCG Matrix, Market entry strategies<\/li>\n<li><strong>Spasticity Unmet Needs, KOL&rsquo;s views, Analyst&rsquo;s views, Spasticity Market Access and Reimbursement&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Spasticity Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary for Spasticity<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis of Spasticity<\/p>\n<p style=\"text-align: justify;\">4. Spasticity Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Spasticity Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Spasticity Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Spasticity Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Spasticity&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Spasticity Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Spasticity Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Spasticity Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Spasticity Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Spasticity Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Spasticity Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Spasticity Market Drivers<\/p>\n<p style=\"text-align: justify;\">16. Spasticity Market Barriers<\/p>\n<p style=\"text-align: justify;\">17.&nbsp; Spasticity Appendix<\/p>\n<p style=\"text-align: justify;\">18. Spasticity Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Spasticity treatment, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/spasticity-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Spasticity Medications<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=spasticity-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-jazz-pharmaceuticals-revance-therapeutics-ipsen-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91 9568243403<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=spasticity-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-jazz-pharmaceuticals-revance-therapeutics-ipsen-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Spasticity market is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Spasticity pipeline products will significantly revolutionize the Spasticity market dynamics. DelveInsight&rsquo;s &ldquo;Spasticity Market Insights, Epidemiology, and Market &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/spasticity-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-jazz-pharmaceuticals-revance-therapeutics-ipsen-and-others_620584.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-620584","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/620584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=620584"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/620584\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=620584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=620584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=620584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}